Sitagliptin Use and its Continuous Glycemic Control Effcets in Japanese patients with type 2 diabetes in Saitama
Not Applicable
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000005076
- Lead Sponsor
- Dokkyo Medical University,Koshigaya Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with type 1 diabetes 2. Renal impairment (Serum creatinine more than 1.5 mg/dl in men or 1.3 mg/dl in women) 4. Patients who undergo surgery 5. Preganat women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. To achieve HbA1c less than 7.0% (JDS values) at 12 weeks after treatment with sitagliptin 2. The time to monotherapy failure
- Secondary Outcome Measures
Name Time Method